| Priorities for cancer research in low-and middle-income countries: a global perspective CS Pramesh, RA Badwe, N Bhoo-Pathy, CM Booth, G Chinnaswamy, ... Nature medicine 28 (4), 649-657, 2022 | 269 | 2022 |
| Temozolomide induces activation of Wnt/β-catenin signaling in glioma cells via PI3K/Akt pathway: implications in glioma therapy VS Tomar, V Patil, K Somasundaram Cell Biology and Toxicology 36, 273-278, 2020 | 73 | 2020 |
| ATF3 and CH25H regulate effector trogocytosis and anti-tumor activities of endogenous and immunotherapeutic cytotoxic T lymphocytes Z Lu, N McBrearty, J Chen, VS Tomar, H Zhang, G De Rosa, A Tan, ... Cell metabolism 34 (9), 1342-1358. e7, 2022 | 43 | 2022 |
| Targeting PARP11 to avert immunosuppression and improve CAR T therapy in solid tumors H Zhang, P Yu, VS Tomar, X Chen, MJ Atherton, Z Lu, HG Zhang, S Li, ... Nature cancer 3 (7), 808-820, 2022 | 40 | 2022 |
| A feedback loop between microRNA 155 (miR-155), programmed cell death 4, and activation protein 1 modulates the expression of miR-155 and tumorigenesis in tongue cancer S Zargar, V Tomar, V Shyamsundar, R Vijayalakshmi, K Somasundaram, ... Molecular and Cellular Biology 39 (6), e00410-18, 2019 | 21 | 2019 |
| Tumor factors stimulate lysosomal degradation of tumor antigens and undermine their cross-presentation in lung cancer Z Lu, J Chen, P Yu, MJ Atherton, J Gui, VS Tomar, JD Middleton, ... Nature communications 13 (1), 6623, 2022 | 17 | 2022 |
| Serine/threonine/tyrosine-interacting-like protein 1 (STYXL1), a pseudo phosphatase, promotes oncogenesis in glioma VS Tomar, TK Baral, K Nagavelu, K Somasundaram Biochemical and biophysical research communications 515 (1), 241-247, 2019 | 15 | 2019 |
| Protection of regulatory T cells from fragility and inactivation in the tumor microenvironment H Zhang, VS Tomar, J Li, R Basavaraja, F Yan, J Gui, N McBrearty, ... Cancer immunology research 10 (12), 1490-1505, 2022 | 10 | 2022 |
| The cancer-associated, gain-of-function TP53 variant P152Lp53 activates multiple signaling pathways implicated in tumorigenesis S Singh, M Kumar, S Kumar, S Sen, P Upadhyay, S Bhattacharjee, ... Journal of Biological Chemistry 294 (38), 14081-14095, 2019 | 8 | 2019 |
| ATF3 and CH25H regulate effector trogocytosis and anti-tumor activities of endogenous and immunotherapeutic cytotoxic T lymphocytes Z Lu, N McBrearty, J Chen, VS Tomar, H Zhang, G De Rosa, A Tan, ... Cell metabolism 36 (5), 1164-1167, 2024 | 1 | 2024 |
| Pooled shRNA screen uncovered the role of SEL1L, an ERAD (endoplasmic reticulum associated degradation) gene, in modulating temozolomide resistance in GBM A Arora, VS Tomar, S Thomas, V Patil, J Hoheisel, K Somasundaram CANCER RESEARCH 78 (13, S), 2018 | 1 | 2018 |
| Genetics of Glioblastoma: Insights into Biology and Therapy Resistance VS Tomar | | 2021 |
| Activation of Multiple Signalling Pathways by P152Lp53 Mutant Reveals New Gain-of-function Implicating Tumorigenesis S Singh, M Kumar, S Kumar, S Sen, P Upadhyay, M Naveen, VS Tomar, ... bioRxiv, 475293, 2018 | | 2018 |
| Abstract LB-098: Pooled shRNA screen uncovered the role of SEL1L, an ERAD (endoplasmic reticulum associated degradation) gene, in modulating temozolomide resistance in GBM A Arora, VS Tomar, S Thomas, V Patil, J Hoheisel, K Somasundaram Cancer Research 78 (13_Supplement), LB-098-LB-098, 2018 | | 2018 |
